These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

745 related articles for article (PubMed ID: 23225017)

  • 1. Familial amyloidotic polyneuropathy and transthyretin.
    Nagasaka T
    Subcell Biochem; 2012; 65():565-607. PubMed ID: 23225017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transthyretin familial amyloid polyneuropathy.
    Planté-Bordeneuve V; Kerschen P
    Handb Clin Neurol; 2013; 115():643-58. PubMed ID: 23931808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transthyretin and familial amyloidotic polyneuropathy. Recent progress in understanding the molecular mechanism of neurodegeneration.
    Hou X; Aguilar MI; Small DH
    FEBS J; 2007 Apr; 274(7):1637-50. PubMed ID: 17381508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin.
    Yazaki M; Tokuda T; Nakamura A; Higashikata T; Koyama J; Higuchi K; Harihara Y; Baba S; Kametani F; Ikeda S
    Biochem Biophys Res Commun; 2000 Aug; 274(3):702-6. PubMed ID: 10924339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deposition of transthyretin amyloid is not accelerated by the same amyloid in vivo.
    Wei L; Kawano H; Fu X; Cui D; Ito S; Yamamura K; Ishihara T; Tokuda T; Higuchi K; Maeda S
    Amyloid; 2004 Jun; 11(2):113-20. PubMed ID: 15478467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clusterin regulates transthyretin amyloidosis.
    Lee KW; Lee DH; Son H; Kim YS; Park JY; Roh GS; Kim HJ; Kang SS; Cho GJ; Choi WS
    Biochem Biophys Res Commun; 2009 Oct; 388(2):256-60. PubMed ID: 19664600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling familial amyloidotic polyneuropathy (Transthyretin V30M) in Drosophila melanogaster.
    Berg I; Thor S; Hammarström P
    Neurodegener Dis; 2009; 6(3):127-38. PubMed ID: 19372706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steady turnover of amyloid fibril proteins in gastric mucosa after liver transplantation in familial amyloid polyneuropathy.
    Tsuchiya-Suzuki A; Yazaki M; Sekijima Y; Kametani F; Ikeda S
    Amyloid; 2013 Sep; 20(3):156-63. PubMed ID: 23826783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of age and sex differences on wild-type transthyretin amyloid formation in familial amyloidotic polyneuropathy: a proteomic approach.
    Tasaki M; Ueda M; Obayashi K; Koike H; Kitagawa K; Ogi Y; Jono H; Su Y; Suenaga G; Oshima T; Misumi Y; Yoshida M; Yamashita T; Sobue G; Ando Y
    Int J Cardiol; 2013 Dec; 170(1):69-74. PubMed ID: 24182678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial amyloidotic polyneuropathy: protein aggregation in the peripheral nervous system.
    João Saraiva M; Mendes Sousa M; Cardoso I; Fernandes R
    J Mol Neurosci; 2004; 23(1-2):35-40. PubMed ID: 15126690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy.
    Taguchi K; Jono H; Kugimiya-Taguchi T; Nagao S; Su Y; Yamasaki K; Mizuguchi M; Maruyama T; Ando Y; Otagiri M
    Life Sci; 2013 Dec; 93(25-26):1017-22. PubMed ID: 24211615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cerebral amyloid angiopathy with familial transthyretin-derived oculoleptomeningeal amyloidosis].
    Ikeda SI
    Brain Nerve; 2013 Jul; 65(7):831-42. PubMed ID: 23832986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transthyretin deposition in familial amyloidotic polyneuropathy.
    Saraiva MJ; Magalhaes J; Ferreira N; Almeida MR
    Curr Med Chem; 2012; 19(15):2304-11. PubMed ID: 22471982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transthyretin-related amyloidotic cardiomyopathy: looking for the etiological treatment].
    Longhi S; Gagliardi C; Milandri A; Manuzzi L; Rapezzi C
    G Ital Cardiol (Rome); 2014 May; 15(5):293-300. PubMed ID: 25002169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New therapeutic approaches for familial amyloidotic polyneuropathy (FAP).
    Ando Y
    Amyloid; 2003 Aug; 10 Suppl 1():55-66. PubMed ID: 14640043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Familial amyloid polyneuropathy].
    Yamashita T; Ando Y; Uchino M
    Brain Nerve; 2011 Jun; 63(6):583-95. PubMed ID: 21613661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transthyretin-related familial amyloidotic polyneuropathy.
    Ando Y; Nakamura M; Araki S
    Arch Neurol; 2005 Jul; 62(7):1057-62. PubMed ID: 16009758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid deposits in transthyretin-derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology.
    Bergström J; Gustavsson A; Hellman U; Sletten K; Murphy CL; Weiss DT; Solomon A; Olofsson BO; Westermark P
    J Pathol; 2005 Jun; 206(2):224-32. PubMed ID: 15810051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between amyloid deposition and intracellular structural changes in familial amyloidotic polyneuropathy.
    Misumi Y; Ueda M; Obayashi K; Jono H; Su Y; Yamashita T; Ohshima T; Ando Y; Uchino M
    Hum Pathol; 2012 Jan; 43(1):96-104. PubMed ID: 21777941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigallocatechin-3-gallate as a potential therapeutic drug for TTR-related amyloidosis: "in vivo" evidence from FAP mice models.
    Ferreira N; Saraiva MJ; Almeida MR
    PLoS One; 2012; 7(1):e29933. PubMed ID: 22253829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.